Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses

The emergent human coronavirus SARS-CoV-2 and its high infectivity rate has highlighted the strong need for new disinfection systems. Evidence has proven that airborne transmission is an important route of spreading for this virus. Therefore, this short communication introduces CLODOS Technology<...

Full description

Bibliographic Details
Main Authors: Sabina Andreu, Inés Ripa, Raquel Bello-Morales, José Antonio López-Guerrero
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/3/531
_version_ 1827696915543752704
author Sabina Andreu
Inés Ripa
Raquel Bello-Morales
José Antonio López-Guerrero
author_facet Sabina Andreu
Inés Ripa
Raquel Bello-Morales
José Antonio López-Guerrero
author_sort Sabina Andreu
collection DOAJ
description The emergent human coronavirus SARS-CoV-2 and its high infectivity rate has highlighted the strong need for new disinfection systems. Evidence has proven that airborne transmission is an important route of spreading for this virus. Therefore, this short communication introduces CLODOS Technology<sup>®</sup>, a novel strategy to disinfect contaminated surfaces. It is a product based on stable and 99% pure chlorine dioxide, already certified as a bactericide, fungicide and virucide against different pathogens. In this study, CLODOS Technology<sup>®</sup>, by direct contact or thermonebulization, showed virucidal activity against the human coronavirus HCoV-229E at non-cytotoxic doses. Different conditions such as nebulization, exposure time and product concentration have been tested to standardize and optimize this new feasible method for disinfection.
first_indexed 2024-03-10T12:58:02Z
format Article
id doaj.art-646292a0d6f942deb9a164ae2007f35f
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T12:58:02Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-646292a0d6f942deb9a164ae2007f35f2023-11-21T11:44:10ZengMDPI AGViruses1999-49152021-03-0113353110.3390/v13030531Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic DosesSabina Andreu0Inés Ripa1Raquel Bello-Morales2José Antonio López-Guerrero3Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, SpainDepartamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, SpainDepartamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, SpainDepartamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, SpainThe emergent human coronavirus SARS-CoV-2 and its high infectivity rate has highlighted the strong need for new disinfection systems. Evidence has proven that airborne transmission is an important route of spreading for this virus. Therefore, this short communication introduces CLODOS Technology<sup>®</sup>, a novel strategy to disinfect contaminated surfaces. It is a product based on stable and 99% pure chlorine dioxide, already certified as a bactericide, fungicide and virucide against different pathogens. In this study, CLODOS Technology<sup>®</sup>, by direct contact or thermonebulization, showed virucidal activity against the human coronavirus HCoV-229E at non-cytotoxic doses. Different conditions such as nebulization, exposure time and product concentration have been tested to standardize and optimize this new feasible method for disinfection.https://www.mdpi.com/1999-4915/13/3/531virucidalnebulizationHCoV-229ESARS-CoV-2
spellingShingle Sabina Andreu
Inés Ripa
Raquel Bello-Morales
José Antonio López-Guerrero
Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
Viruses
virucidal
nebulization
HCoV-229E
SARS-CoV-2
title Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_full Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_fullStr Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_full_unstemmed Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_short Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses
title_sort nebulized clodos technology shows clear virucidal properties against the human coronavirus hcov 229e at non cytotoxic doses
topic virucidal
nebulization
HCoV-229E
SARS-CoV-2
url https://www.mdpi.com/1999-4915/13/3/531
work_keys_str_mv AT sabinaandreu nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses
AT inesripa nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses
AT raquelbellomorales nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses
AT joseantoniolopezguerrero nebulizedclodostechnologyshowsclearvirucidalpropertiesagainstthehumancoronavirushcov229eatnoncytotoxicdoses